2022
BMJ (Clinical research ed.), (2022).378, 10.1136/bmj.o2320.
2022
PLOS global public health, (2022).2 10 10.1371/journal.pgph.0000800.
2022
Parasite Immunology, (2022).44 9 10.1111/pim.12939.
2022
The Lancet. Infectious diseases, (2022).22 9 10.1016/s1473-3099(22)00454-6.
Cost-effectiveness of shortened regimens for DR-TB.
2022
(2022).
2022
RSC Medicinal Chemistry, (2022).13 11 10.1039/d2md00155a.
PRACTECAL regimens for MDR-TB: Preliminary cost-effectiveness analysis.
2022
(2022).
2022
BMC Infectious Diseases, (2022).22 1 10.1186/s12879-022-07677-9.
2022
International Journal of Tuberculosis and Lung Disease, (2022).26 5 10.5588/ijtld.21.0622.
2022
The Lancet Infectious diseases, (2022).22 9 10.1016/S1473-3099(22)00452-2.